HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

INFU

InfuSystem Holdings, Inc. (AMEX)

Healthcare — Medical Devices

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

None 4 analysts
$10.02
+$0.37 (+3.83%)
Target: $14.88 (48.5%)
Sign in to add INFU to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$202.22M
P/E Ratio (TTM)27.08
Forward P/E22.77
EPS (TTM)$0.37
Dividend Yield-
Profit Margin5.55%
Revenue Growth-3.00%
ROE13.89%
Debt/Equity41.03
Recommendation None
Analyst Target$14.88
Analysts4
Indexes AMEX

Technical Indicators

RSI (14)64.5
Beta1.42
SMA 20-
SMA 40-
52-Week High$11.04
52-Week Low$5.38
50-Day Avg$9.41
200-Day Avg$9.33
Avg Volume215.4K
Volume141.3K

Performance Analysis

BULLISH

INFU shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 82% of its 52-week range.
+ RSI at 64.5 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- Revenue declined 3.0% year-over-year.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $14.88 implies 48.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:15 UTC

Back to Screener Export Report